Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer

被引：0
|
作者：
YAO Yang SUN Yuanjue ZHAO Hui GUO Yuewu LIN Feng CAI Xun TANG Xiaochun TANG Lina and ZHANG Wei Department of Oncology Shanghai Sixth Peoples Hospital of Shanghai Jiaotong University Shanghai China Department of Epidemiology Cancer Research Institute of Shanghai Jiaotong University Shanghai China [200233 ,200032 ]
机构：
来源：
Chinese Medical Journal. | 2006年 / 21期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer
    YAO Yang
    [J]. 中华医学杂志(英文版), 2006, (21) : 1829 - 1833
  • [2] Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer
    Yao Yang
    Sun Yuan-jue
    Zhao Hui
    Guo Yue-Wu
    Lin Feng
    Cai Xun
    Tang Xiao-chun
    Tang Li-na
    Zhang Wei
    [J]. CHINESE MEDICAL JOURNAL, 2006, 119 (21) : 1829 - 1833
  • [3] Clinical Study of Combining Chemotherapy of Oxaliplatin or 5-Fluorouracil/Leucovorin with Hydroxycamptothecine for Advanced Colorectal Cancer
    Yuanjue Sun Hui Zhao Yaowu Guo Feng Lin Lina Tang Yang Yao Department of Medical Oncology
    [J]. Cancer Biology & Medicine, 2009, (02) : 117 - 123
  • [4] Phase III study of 5-fluorouracil/leucovorin plus oxaliplatin versus capecitabine plus oxaliplatin as first line therapy in patients with advanced colorectal cancer (ACRC)
    Porschen, R
    Arkenau, T
    Kubicka, S
    Schmoll, HJ
    Seufferlein, T
    Graeven, U
    Grothey, A
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A438 - A438
  • [5] Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer
    Ducreux, Michel
    Bennouna, Jaafar
    Hebbar, Mohamed
    Ychou, Marc
    Lledo, Gerard
    Conroy, Thierry
    Adenis, Antoine
    Faroux, Roger
    Rebischung, Christine
    Bergougnoux, Loic
    Kockler, Leila
    Douillard, Jean-Yves
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (03) : 682 - 690
  • [6] PHARMACOECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS 5-FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE FIRST LINE TREATMENT OF METASTASIS COLORECTAL CANCER IN TAIWAN
    Chen, H. H.
    Chang, C. S.
    Chen, L. T.
    Chen, W. T.
    Hsu, T. C.
    Wang, J. Y.
    Wen, C. Y.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A278 - A278
  • [7] Treatment of advanced gastric cancer with oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4 chemotherapy)
    Garrido, Marcelo
    Melgoza, Geraldine
    Galindo, Hector
    Madrid, Jorge
    Sanchez, Cesar
    Nervi, Bruno
    Alvarez, Manuel
    Orellana, Eric
    [J]. REVISTA MEDICA DE CHILE, 2007, 135 (11) : 1380 - 1387
  • [8] Oxaliplatin plus 5-fluorouracil: Clinical experience in patients with advanced colorectal cancer
    Bleiberg, H
    de Gramont, A
    [J]. SEMINARS IN ONCOLOGY, 1998, 25 (02) : 32 - 39
  • [9] ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED GASTRIC CANCER IN CHINA
    Chen, W.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A514 - A514
  • [10] Oxaliplatin combined with 5-fluorouracil, leucovorin regimen for patients with advanced colorectal cancer
    Suyi Li
    [J]. Oncology and Translational Medicine, 2007, (03) : 225 - 227
12345